Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$317,639
-$136,246 QoQ
Shares Held
13,191
-18.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,086
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Shields Capital Management, LLC holds $19,991,464 across 9 Drug Manufacturers - General names. PFE ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,793 | $11,746,018 | |
| 2 | JNJ |
Johnson & Johnson
|
12,573 | $3,193,164 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,175 | $1,307,487 | |
| 4 | AMGN |
Amgen Inc
|
3,578 | $1,295,665 | |
| 5 | ABBV |
AbbVie Inc.
|
4,721 | $1,187,992 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,407 | $714,891 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,191 | $317,639 | |
| 8 | GSK |
GSK plc
|
3,103 | $162,659 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317,639 | 13,191 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $453,885 | 16,164 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $373,699 | 15,008 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $370,275 | 14,532 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $362,509 | 14,955 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $542,985 | 21,428 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $637,224 | 24,019 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $860,386 | 29,730 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $848,157 | 30,313 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $853,312 | 30,750 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $874,208 | 30,365 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,078,787 | 32,523 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $823,942 | 22,463 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $969,000 | 23,750 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,578,704 | 30,810 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,354,547 | 30,954 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,625,172 | 30,997 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,459,644 | 47,511 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,229,042 | 71,618 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,328,346 | 54,135 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,081,578 | 78,692 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,398,917 | 93,815 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,856,436 | 104,766 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,573,145 | 97,361 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,234,262 | 98,907 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,123,088 | 95,683 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||